Search research articles
Contact Us
Filters
Showing results (111-120 of 187) with videos related to
Page
of 19
Sort By:
The Journal of Investigative Dermatology
|
June 10, 2026
Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis
Yoni Sacknovitz, Rachel Ma, Maggie H Zhou, et al.
Cancer
|
August 28, 2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy
Bouthaina S Dabaja, Peter McLaughlin, Chul S Ha, et al.
Seminars in Oncology
|
December 18, 2017
Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment
Lekha Mikkilineni, Diana Whitaker-Menezes, Marina Domingo-Vidal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood
|
July 12, 2017
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)
Joonhee Park, Jingyi Yang, Alexander T Wenzel, et al.
Hematological Oncology
|
August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel
Pietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
Journal of Hematology & Oncology
|
January 25, 2014
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Leukemia & Lymphoma
|
June 22, 2019
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status
Amir Behdad, Craig S Boddy, Angela J Fought, et al.
Blood
|
March 7, 2018
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas
Michelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Blood
|
January 11, 2003
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies
Stefan Faderl, Deborah A Thomas, Susan O'Brien, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 187) with videos related to
Sort By:
Page
of 19
The Journal of Investigative Dermatology
|
June 10, 2026
Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis
Yoni Sacknovitz, Rachel Ma, Maggie H Zhou, et al.
Cancer
|
August 28, 2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy
Bouthaina S Dabaja, Peter McLaughlin, Chul S Ha, et al.
Seminars in Oncology
|
December 18, 2017
Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment
Lekha Mikkilineni, Diana Whitaker-Menezes, Marina Domingo-Vidal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood
|
July 12, 2017
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)
Joonhee Park, Jingyi Yang, Alexander T Wenzel, et al.
Hematological Oncology
|
August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel
Pietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
Journal of Hematology & Oncology
|
January 25, 2014
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Leukemia & Lymphoma
|
June 22, 2019
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status
Amir Behdad, Craig S Boddy, Angela J Fought, et al.
Blood
|
March 7, 2018
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas
Michelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Blood
|
January 11, 2003
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies
Stefan Faderl, Deborah A Thomas, Susan O'Brien, et al.
Page
of 19